Drosophila, but how PKA activity is regulated remains elusive. Here, we identify a novel regulator of the Hh pathway, the capping-enzyme mRNAcap, which positively regulates Hh signaling activity through modulating PKA activity. We provide genetic and biochemical evidence that mRNA-cap inhibits PKA kinase activity to promote Hh signaling. Interestingly, regulation of Hh signaling by mRNA-cap depends on its cytoplasmic capping-enzyme activity. In addition, we show that the mammalian homolog of mRNA-cap, RNGTT, can replace mRNA-cap to play the same function in the Drosophila Hh pathway and that knockdown of Rngtt in cultured mammalian cells compromised Shh pathway activity, suggesting that RNGTT is functionally conserved. Our study makes an unexpected link between the mRNA capping machinery and the Hh signaling pathway, unveils a new facet of Hh signaling regulation, and reveals a potential drug target for modulating Hh signaling activity.
primary role because its phosphorylation of Ci provides priming sites for GSK3-and CK1-mediated phosphorylation 23, 27, 33, 36 .
In A-cells near the A/P boundary where Hh is present, Hh induces Smo activation by promoting phosphorylation of its C-terminal tail by PKA and CK1, which increases Smo cell-surface expression and converts Smo from a closed, inactive conformation to an open and active one 14, [37] [38] [39] . Activated Smo inhibits Ci processing and converts Ci F into an active form (Ci A ) that activates the Hh target genes including ptc and en 40, 41 . Hence, PKA plays a dual role in the Hh pathway by activating Smo but inhibiting Ci depending on the availability of the Hh ligand. Despite its dual role in Hh signaling, loss of PKA results in Hh pathway activation instead of inhibition due to the depression of Ci: loss of Ci R and accumulation of Ci F , some of which is converted into Ci A 24, 42 .
Drosophila mRNA-cap is a capping enzyme that harbors a RNA 5′-triphosphatase and mRNA 3′-guanylyltransferase domains and catalyzes the attachment of the 5′ cap to messenger RNA molecules in the nucleus during the first stage of gene expression [43] [44] [45] [46] [47] [48] . Cap removal is considered to be a prerequisite step in the mRNA degradation pathway 49 , but recent findings indicate that certain portion of translational inactive mRNAs might be stored in an uncapped state and subsequently returned to an active state upon cytoplasmic re-capping 50 . In this case, capping enzyme cooperates with a novel kinase to generate capped ends from cleaved RNAs in cytoplasm, which is named cytoplasmic capping. Except for its capping function, other functions of mRNA-cap are elusive. In this study, we find unexpectedly that mRNA-cap regulates Hh signaling activity depending on its capping-enzyme activity in the cytoplasm. Furthermore, we find that it regulates Hh signaling through antagonizing PKA.
Results
Downregulation of mRNA-cap disrupts wing development. Given that Hh pathway plays an important role in wing development and its deregulation causes wing development defect, we sought to identify novel regulators of Hh signaling via analyzing wing phenotypes caused by either loss or gain of function of such regulators. To do that, we performed in vivo RNAi screen by silencing ~7000 genes that are conserved between Drosophila and mammals using a wing specific Gal4 driver MS1096-Gal4 and determined which genes modulated wing development. We picked up the candidate genes whose knockdown caused abnormal wing phenotypes, and further investigated whether they modulated Hh signaling activity by examining the pathway target gene ptc-lacZ via immunostaining. In our screen, we found that knockdown of mRNA-cap through its RNAi line (VDRC 108809) disrupted wing development, causing deformed wing phenotype (Fig. 1A,B ). To verify the efficiency of this RNAi line and rule out any off-target effect, we made UAS-HA-mRNA-cap transgenic flies. Through co-expressing the transgene and the RNAi line, we found that mRNA-cap transgenic expression could rescue the RNAi-induced abnormal wing phenotype (Fig. 1C ), suggesting that the aberrant wing phenotype is indeed caused by loss of mRNA-cap. We also employed another mRNA-cap RNAi line (Bloomington 32847), which is a relatively weaker line compared with 108809, and observed a similar wing defect ( Supplementary Fig. 1A ), and this defect was also rescued by overexpressing the mRNA-cap transgene ( Supplementary Fig. 1B ). Taken together, these results indicate that mRNA-cap is essential for normal wing formation in Drosophila.
Knockdown of mRNA-cap represses Hh signaling activity.
Since mRNA-cap knockdown disrupts the wing morphology and many signaling pathways including Hh, Wingless, Notch and Hippo pathways are involved in the regulation of the wing development, we tested whether mRNA-cap knockdown affects these pathways. We found that Wingless, Notch and Hippo signaling pathway activities exhibited little if any changes when mRNA-cap was knocked down, as monitored by their cognate read-outs Dll-lacZ ( Fig. 2A,B ), Cut (Fig. 2C,D) and Ex-lacZ ( Fig. 2E ,F) respectively. However, we found that mRNA-cap RNAi downregulated the expression of Hh pathway target genes including dpp-lacZ, ptc-lacZ and En (Fig. 2H ,J and L compared with Fig. 2G ' ,I' and K'), suggesting that mRNA-cap selectively modulates Hh signaling activity.
In order to future test the function of mRNA-cap in the Hh pathway, we detected the Ci and found that the level of Ci F was downregulated by mRNA-cap RNAi (Fig. 2M ). We obtained similar results using an independent RNAi line (32847) targeting mRNA-cap ( Supplementary Fig. 1C -C"'). To confirm the function of mRNA-cap in the Hh pathway, we employed the FLP-FRT mitotic recombination technique to generate homozygous clones for an mRNA-cap mutant, mRNA-cap A . Consistent with the observation that mRNA-cap RNAi downregulated Ci F level, mRNA-cap A clones, which are marked by lack of GFP expression ( Fig. 2N ,O), showed decreased Ci F level ( Fig. 2N' ,O' ). Furthermore, co-expression of HA-mRNA-cap with mRNA-cap RNAi rescued the expression of Ci F and ptc-lacZ ( Fig. 2P,P' ). These observations indicate that mRNA-cap exerts a positive influence on Hh pathway activity. To distinguish whether Ci downregulation by mRNA-cap RNAi occurs at mRNA or protein level, we examined the transcript level of ci using the ci-lacZ reporter that expresses lacZ under the control of ci promotor. We didn't find any difference in ci-lacZ expression between the control and mRNA-cap knockdown wing discs ( Fig. 3G-H' ), indicating that ci transcription is not regulated by mRNA-cap. To exclude that mRNA-cap affects Ci mRNA stability, we measured ci mRNA level by RT-qPCR in wing discs and found that mRNA-cap RNAi didn't affect ci mRNA level ( Fig. 3I ). Meanwhile we found that mRNA-cap did not affect the smo mRNA level (Fig. 3I ). Taken together, the RT-qPCR results imply that mRNA-cap affects Ci and Smo at protein level instead of mRNA level. To test the genetic interaction between mRNA-cap and PKA, we expressed mRNA-cap RNAi and PKA-C1 RNAi (VDRC 101524) transgenes individually or in combination. As shown in Fig To further test this idea, we overexpressed Ci WT or Ci −3p (a constitutively active form of Ci with three PKA sites mutated to Ala) with mRNA-cap RNAi and found that mutating the PKA sites in Ci renders it resistant to mRNA-cap RNAi-mediated downregulation ( Fig. 4I-L' ). Phosphorylation of Ci by PKA targets it for Slimb-mediated degradation 24, 53 . We found that knockdown of slimb either alone or together with mRNA-cap upregulated Ci (Fig. 4M,N) . Taken together, these results suggest that mRNA-cap regulates Smo and Ci through PKA.
mRNA-cap regulates
mRNA-cap inhibits the PKA activity in wing discs. The above genetic evidence suggests that mRNA-cap regulates Hh signaling activity through PKA. Next, we tested whether PKA activity is altered upon knockdown of mRNA-cap. We found that the PKA activity was increased by mRNA-cap RNAi in wing discs ( Fig. 5A ). As PKA activity is regulated by cAMP, we further tested whether mRNA-cap regulated PKA activity through cAMP and found that cAMP level was not changed when mRNA-cap was knocked down (Fig. 5B ).
In Drosophila, there are two PKA regulatory subunits: PKA-R1, R2 and three PKA catalytic subunits: PKA-C1, C2 and C3. We generated transgenic flies expressing these PKA subunits under the control of UAS promoter. Except for PKA-C2, over-expression of all other transgenes had the expected effects on Hh signaling; however, the effect of PKA-C3 overexpression on Hh signaling was relatively weak compared with PKA-C1 ( Fig. 5C -F"'). We further examined the endogenous mRNA levels of these PKA subunits upon knockdown of mRNA-cap, and found no obvious changes despite of efficient knockdown of mRNA-cap ( Fig. 5G) .
As PKA-C1 and PKA-R1 are predominantly expressed in wing discs compared with other PKA subunits ( Fig. 5G ), their protein levels were further investigated. Comparing the MS1096 > mRNA-cap RNAi with control wing discs, we found that neither PKA-C1 nor PKA-R1 exhibited significant changes in their protein levels ( Fig. 5H,I) . Taken together, these results suggest that mRNA-cap regulates PKA activity independent of cAMP and the protein levels of PKA regulatory and catalytic subunits.
We next examined whether mRNA-cap affects the interaction between the regulatory and catalytic subunits and found that mRNA-cap didn't affect R1/R1, C1/C1, C1/R1 dimer formation ( mRNA-cap regulates Hh signaling through its enzyme activity. To test which domain of mRNA-cap is essential for its regulation of Hh signaling, we generated two transgenes: HA-mRNA-cap-N (aa1-272) and HA-mRNA-cap-C (aa248-616), which harbor the N-terminal 5′-triphosphatase domain and the C-terminal guanylyltransferase domain, respectively. We co-expressed mRNA-cap RNAi with HA-mRNA-cap, HA-mRNA-cap-N or HA-mRNA-cap-C and found that only HA-mRNA-cap rescued the adult wing phenotype (Fig. 6B "') as well as the expression of Ci, ptc-lacZ and Smo to wild type levels ( Fig. 6B-B" ), whereas neither HA-mRNA-cap-N nor HA-mRNA-cap-C could rescue the RNAi phenotypes ( Fig. 6C -D"'), indicating that both N-and C-terminus of mRNA-cap are essential for its function in the Hh signaling pathway.
We next generated transgenic flies expressing two mutant forms of mRNA-cap, mRNA-cap MP and mRNA-cap MG , which mutated the essential residues in the triphosphatase and guanylyltransferase domains, respectively (Fig. 6A) 48 . We found that neither mRNA-cap MP nor mRNA-cap MG could rescue the abnormal wing phenotypes as well as the abnormal expression of Ci, ptc-lacZ and Smo caused by mRNA-cap RNAi (Fig. 6E-F"') . These results suggest that modulation of Hh signaling by mRNA-cap may depend on its capping enzyme activity. This notion was further supported by the fact that a single amino acid substitution in mRNA-cap, mRNA-cap R569K , which affects its interaction with poly (U) and disrupts the capping enzyme activity in mammalian 48 , affected its ability to rescue Hh signaling defects caused by mRNA-cap RNAi (Fig. 6G-M) . Taken together, these results suggest that mRNA-cap regulates Hh signaling activity depending on its capping enzyme activity.
To define where mRNA-cap exerts its influence on Hh signaling, we transfected HA-mRNA-cap in S2 cells and found that it is located in both cytoplasm and nucleus ( Fig. 7A-A") . Treating the cells with the nuclear export inhibitor LMB resulted in an exclusive nuclear localization of HA-mRNA-cap ( Fig. 7B-B" ), suggesting that mRNA-cap shuttles between the nucleus and cytoplasm and may modulate PKA activity in the cytoplasm, nucleus or both. To determine where mRNA-cap acts, we overexpressed an mRNA-cap variant, HA-NES-RNGTT△NLS, which is exclusively localized in the cytoplasm both in the S2 cells and in the wing discs ( Fig. 7C-D" ), and found that it could rescue the Ci, ptc-lacZ, Smo levels ( Fig. 7E -E"') as well as adult wing phenotype in mRNA-cap RNAi background ( Fig. 7E"" ). On the other hand, a capping enzyme-dead cytoplasmic form of mRNA-cap, HA-NES-RNGTT△NLS K294A (Fig. 7F-G") failed to rescue the Hh pathway defects caused by mRNA-cap RNAi (Fig. 7H-H"") . These results suggest that mRNA-cap can regulate Hh signaling in the cytoplasm through its capping enzyme activity.
Mammalian mRNA-cap is functionally conserved. Our above results show mRNA-cap regulates Hh signaling activity. To test whether mammalian mRNA-cap is functionally conserved throughout evolution, we sub-cloned RNGTT, the homolog of mRNA-cap in humans, into the UAS vector and generated transgenic flies carrying UAS-RNGTT. Co-expression of UAS-RNGTT with the mRNA-cap RNAi transgene rescued the wing phenotype and restored the normal levels of Ci, ptc-lacZ and Smo (Fig. 8A-A"' ), suggesting that RNGTT could substitute Drosophila mRNA-cap to regulate Hh signaling, indicating that mRNA-cap is functionally conserved between Drosophila and mammals. Furthermore, mutating the essential residues in the 5′-triphosphatase (MP) or the 3′-guanylyltransferase (MG) domain of human RNGTT or a single point mutation (K294A) in RNGTT, which eliminated its guanylylation function 54 , all prevented it from rescuing the Hh signaling defects and adult wing phenotypes caused by mRNA-cap RNAi (Fig. 8B-D"') . Taken together, the results suggest that RNGTT is functionally conserved during evolution, and it can substitute mRNA-cap to modulate Hh singling depending on the capping enzyme activity.
To further confirm the conservation of mRNA-cap function in the Hh signaling pathway, we performed the Gli-luciferase reporter assay in NIH/3T3 cells, which was regulated by Sonic hedgehog (Shh) pathway components. Results from the reporter assay showed that overexpression of RNGTT promoted Gli-luciferase activity whereas RNGTT K294A decreased the Hh pathway activity (Fig. 8E) . Consistently, knockdown of endogenous RNGTT suppressed Gli-luciferase activity (Fig. 8F) , indicating that RNGTT is a functionally conserved positive regulator in the Shh pathway. Meanwhile, we found that expression of the mammalian homolog of PKA-R1, PRKAR1A, increased the expression of Gli-luciferase reporter gene in both control and RNGTT knockdown cells (Fig. 8F) . We obtained the similar results when cells were treated with ShhN (Fig 8G,H) . Taken together, these results support that RNGTT regulates Shh pathway activity through PKA.
Discussion
Hh signaling plays essential roles in embryonic development and adult tissue homeostasis, and its misregulation causes numerous human diseases including birth defects and cancers. PKA modulates Hh signaling activity through phosphorylation of the transcription factor Ci/Gli and the GPCR family protein and Hh signal transducer Smo. Besides the regulation of PKA-substrate interaction 55 and possible involvement of Gαi 56 , how PKA activity is regulated remains poorly understood. In this study, we identify a novel regulator of the Hh pathway, the capping-enzyme mRNA-cap, which positively regulates Hh signaling activity through modulating PKA activity ( Fig. 9 ). Interestingly, we demonstrate that the regulation of Hh signaling by mRNA-cap can be achieved by its cytoplasmic capping-enzyme activity. Finally, we show that the mammalian homolog of mRNA-cap, RNGTT, plays a conserved role in the regulation of Hh signaling. Interestingly, it has been reported recently that mRNA capping machinery can regulate specific gene expression, and is involved in the maintenance of pluripotency and differentiation of embryonic stem cell (ESC), the regulation of G1 Phase transcripts, and the regulation of the Wnt/β-catenin signaling activity [57] [58] [59] . Here, our study links the mRNA capping machinery to another important developmental signaling pathway, Hh signaling pathway, unveils a new facet of Hh signaling regulation and uncovers a potential new target for modulating Hh signaling activity in the treatment of cancer.
As shown in Flybase, Drosophila has only one capping enzyme encoded by mRNA-cap, which harbors an RNA 5′-triphosphatase domain and an mRNA 3′-guanylyltransferase domain and catalyzes the attachment of the 5′ cap to messenger RNA molecules in the nucleus during the first stage of gene expression. Ubiquitous knockdown of mRNA-cap causes fly lethality. In addition, in situ hybridization assay reveals that its expression is ubiquitous in Drosophila wing discs ( Supplementary Fig. 1D,D' ). These observations suggest that mRNA-cap is an essential gene for fly development. Surprisingly, knockdown of mRNA-cap can selectively affect Hh signaling without affecting several other signaling pathways we have tested. Our results indicate that mRNA-cap shuttles between the cytoplasm and the nucleus, implying that mRNA-cap may also play a role in the cytoplasm in addition to its well-characterized function in nucleus. As mentioned before, mRNA-cap can recap a selective fraction of translationally inactive mRNAs to return them to an active state through cytoplasmic re-capping mechanism 50 . In this case, there may be only a small number of genes that are controlled by mRNA-cap through cytoplasmic capping function, one of which could be involved in regulating PKA and Hh signaling. As shown in Fig. 7 and Supplementary Fig. 3A,B , the results in both Drosophila and the NIH/3T3 cells support this idea.
How mRNA-cap affects PKA activity is not resolved and remains an important issue to address by future study. The PKA holoenzyme consists of two catalytic (C) subunits and two regulatory (R) subunits, cAMP binding to R subunit and the subsequent dissociation between R and C subunits are needed for PKA activity. Our results indicate that knockdown of mRNA-cap upregulated PKA activity, but did not affect cAMP level, PKA-R1, R2, C1, C3 mRNA levels and R1, C1 protein levels. Neither did it affect PKA-R1/R1, C1/C1 and R1/C1 interaction. In addition, the regulation of Hh signaling by mRNA-cap is dependent on its cytoplasmic capping-enzyme activity, and knockdown of the mRNA cap binding protein, Cbp80, showed similar Hh signaling defects ( Supplementary  Fig. 4A-C) , indicating that the mRNA capping machinery is involved in the regulation of Hh signaling activity. Since PKA can directly bind Smo and Cos2 36, 55 , we also carried out experiments to exclude the possibility that mRNA-cap regulates the interactions of Cos2-PKA and Smo-PKA ( Supplementary Fig. 5A,B) . Taken together, our results suggest that mRNA-cap may regulate an unidentified factor that is involved in the inhibition of PKA activity through a non-canonical mechanism.
Importantly, our results indicate that mRNA-cap function is conserved during evolution. Given that PKA plays essential roles in developmental and adult homeostasis as well as a variety of physiological conditions, our study suggests an alternative way to modulate PKA activity and indicates that mRNA-cap and its relevant target genes may be the potential drug targets for the treatment of Hh-or PKA-related diseases. 60 . mRNA-cap A is an mRNA-cap mutant allele, whose tyrosine (Y) at 346 is replaced by alanine (A) (Flybase). The transgenic flies of HA-mRNA-cap, HA-mRNA-cap MP , HA-mRNA-cap MG , HA-mRNA-cap-N, HA-mRNA-cap-C, HA-mRNA-cap R569K , HA-RNGTT, HA-RNGTT MP , HA-RNGTT MG , HA-RNGTT K294A , HA-PKA-C2, HA-PKA-C3, HA-PKA-R1, Myc-PKA-R2, HA-NES-RNGTT△NLS and HA-NES-RNGTT△NLS K294A were generated by injection of corresponding constructs into Drosophila embryos according to the methods described previously 61 . The parental strain for all germline transformations was w 1118 . All stocks used in this study were maintained and raised under standard conditions. Immunostaining and in situ hybridization. Immunostaining and in situ hybridization of imaginal discs were performed according to the standard protocols 53, 62 . Antibodies were used in this study as follows: rat anti-Ci (2 A) (DSHB, 1:50), mouse anti-Flag (M2) (Sigma,1:200), mouse anti-HA (F7) (Santa Cruz, 1:200), mouse anti-Myc (9E10) (Santa Cruz, 1:5000), mouse anti-β-galactosidase (Sigma, 1:500), mouse anti-En (DSHB, 1:50), mouse anti-Smo (DSHB, 1:50), mouse anti-Cut (DSHB, 1:50), 4,6-iamidino-2-phenylindole dihydrochloide (DAPI) (Santa Cruz, 1:1000). Secondary antibodies used in this study were bought from Jackson ImmunoResearch, and then were diluted at 1:500. For LMB (Sigma) treatment, S2 cells were treated with LMB at a final concentration of 5 nM for 2 h before cells were harvested for mRNA-cap localization assay. For in situ hybridization assay, the primers for mRNA-cap sub-cloning as follows: mRNA-cap upstream 5′-GTTATATGATGCTCATCGAT-3′; mRNA-cap downstream 5′-TTAATTTCCTAATGTCGGGT-3′; the corresponding of cDNA of mRNA-cap was cloned into pBluescript vector. mRNA-cap probe was prepared according to the instruction of the DIG RNA labeling kits (Roche).
Materials and Methods

Constructs
Cell culture, Transfection, RNAi interference, Immunoprecipitation, and Western blot assay. S2 cells were maintained at 25 °C in Schneider′s Drosophila Medium (S9895, Sigma) supplemented with 10% FBS (F0718, Gibco) and 1% penicillin/streptomycin (P0781, Sigma). Transfection was performed using calcium phosphate according to the manufacturer's instructions (Invitrogen). Usually S2 cells are transfected in 10-cm plates with no more than 20 μg of total DNA for an ubiquitin-Gal4 construct and other co-transfected pUAST expression vectors. 48 hrs after transfection, cells are harvested for immunoprecipitation and western blot analysis with standard protocols as previously described 40 . NIH/3T3 cells were cultured at 37 °C in an atmosphere of 5% CO 2 , in Dulbecco's modified Eagle's medium (DMEM; Life Technologies) supplemented with 10% FBS (F0718, Gibco) and 1% penicillin/streptomycin (P0781, Sigma). Indicated plasmids were transfected into cells with Lipofectamine 2000 (Invitrogen) according to manufacturer's instructions. The following antibodies were used for immunoprecipitation and immunoblotting: mouse anti-Myc (9E10) (Santa Cruz, 1:5000), mouse anti-HA (Santa Cruz, 1:5000), mouse anti-Flag (M2) (Sigma, 1:5000), mouse anti-β-actin (GenScript, 1:10000), rabbit anti-PKAα (Santa Cruz, 1:500), rabbit anti-PKAIβ (Santa Cruz, 1:500), goat anti-rabbit HRP (1:10000; Jackson ImmunoResearch) and goat anti-mouse HRP (1:10000; Jackson ImmunoResearch). For RNA interference experiment, dsRNA was generated through in vitro transcription by using the MEGAscript T7 kit (Ambion). S2 cells were cultured in serum-free medium containing dsRNA for 12 hrs at 25 °C before transfection with DNA constructs. Then the culture medium was changed to serum medium and additional culturing for 48 hrs 63 . The primer sequences of mRNA-cap dsRNA are as follows: upstream 5′-GTTATATGATGCTCATCGAT-3′, downstream 5′-TTAATTTCCTAATGTCGGGT-3′. Western blot was performed as the standard protocols (described in Molecular Cloning). To silence RNGTT expression in 3T3 cells, the RNGTT siRNA was used (RiboBio). The sequence was 5′-GGAACCAUUUAGCGUCAGAdTdT-3′. All siRNA duplexes were transfected at a final
